ZBH
Zimmer Biomet Holdings, Inc. Healthcare - Medical Devices Investor Relations →
Zimmer Biomet Holdings, Inc. (ZBH) closed at $82.90 as of 2026-05-01, trading 24.0% below its 200-week moving average of $109.06. This places ZBH in the extreme value zone. The stock is currently moving closer to the line, down from -16.4% last week. The 14-week RSI sits at 46, indicating neutral momentum.
A big spike in selling this week — 2.4x the usual volume, and the price dropped. Sometimes this kind of heavy selling marks the end of a decline. The idea is that the last reluctant holders have finally sold, leaving fewer sellers left to push the price lower.
Over the past 1244 weeks of data, ZBH has crossed below its 200-week moving average 18 times. On average, these episodes lasted 25 weeks. Historically, investors who bought ZBH at the start of these episodes saw an average one-year return of +10.2%.
With a market cap of $16.0 billion, ZBH is a large-cap stock. The company generates a free cash flow yield of 6.1%, which is healthy. Return on equity stands at 6.1%. The stock trades at 1.3x book value.
The company has been aggressively buying back shares, reducing its share count by 6.5% over the past three years.
Over the past 23.8 years, a hypothetical investment of $100 in ZBH would have grown to $264, compared to $1218 for the S&P 500. ZBH has returned 4.1% annualized vs 11.1% for the index, underperforming the broader market over this period.
Free cash flow has been growing at a 10% compound annual rate, with 4 consecutive years of positive cash generation. A business generating more cash every year while trading below its 200-week moving average is exactly the kind of disconnect value investors look for.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: ZBH vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ZBH Crosses Below the Line?
Across 18 historical episodes, buying ZBH when it crossed below its 200-week moving average produced an average return of +8.0% after 12 months (median +13.0%), compared to +9.0% for the S&P 500 over the same periods. 72% of those episodes were profitable after one year. After 24 months, the average return was +9.8% vs +20.8% for the index.
Each line shows $100 invested at the moment ZBH crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ZBH has crossed below its 200-week MA 18 times with an average 1-year return of +10.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Jul 2002 | Jul 2002 | 2 | 3.5% | +47.6% | +216.6% |
| Apr 2006 | Aug 2006 | 15 | 17.3% | +44.7% | +53.3% |
| Oct 2007 | Jan 2008 | 14 | 15.0% | -37.0% | +41.2% |
| Feb 2008 | Mar 2008 | 2 | 0.3% | -53.5% | +28.1% |
| Apr 2008 | Jan 2011 | 145 | 53.3% | -40.2% | +29.3% |
| Aug 2011 | Jan 2012 | 22 | 15.2% | +16.0% | +81.2% |
| Nov 2016 | Nov 2016 | 1 | 1.8% | +13.9% | -5.9% |
| Nov 2016 | Dec 2016 | 1 | 0.1% | +15.3% | -7.9% |
| Mar 2018 | Apr 2018 | 5 | 5.1% | +18.9% | -15.0% |
| May 2018 | May 2018 | 1 | 0.2% | +4.0% | -17.9% |
| Jun 2018 | Jul 2018 | 1 | 0.3% | +6.5% | -18.2% |
| Jul 2018 | Jul 2018 | 1 | 0.0% | +11.5% | -18.5% |
| Nov 2018 | Jan 2019 | 10 | 12.0% | +28.7% | -19.5% |
| Mar 2020 | May 2020 | 10 | 28.6% | +68.2% | -8.1% |
| Jun 2020 | Jul 2020 | 3 | 3.8% | +44.7% | -22.3% |
| Nov 2021 | Apr 2023 | 72 | 20.6% | -8.0% | -31.1% |
| May 2023 | Jun 2023 | 2 | 1.7% | -8.1% | -33.3% |
| Jul 2023 | Ongoing | 144+ | 24.0% | Ongoing | -32.7% |
| Average | 25 | — | +10.2% | — |
Frequently Asked Questions
Is ZBH below its 200-week moving average?
Yes. As of 2026-05-01, Zimmer Biomet Holdings, Inc. (ZBH) is trading 24.0% below its 200-week moving average of $109.06. The current price is $82.90.
What is ZBH's 200-week moving average price?
Zimmer Biomet Holdings, Inc.'s 200-week moving average is $109.06 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when ZBH drops below its 200-week moving average?
ZBH has crossed below its 200-week moving average 18 times in our data. On average, buying at that moment produced a one-year return of +10.2%. These dips have historically been decent entry points. These episodes lasted 25 weeks on average.
Is ZBH a good value right now?
Here's what our data says about ZBH as of 2026-05-01: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 46. Free cash flow yield is 6.1%. Return on equity is 6.1%. Price-to-book is 1.3x. This is not a buy or sell recommendation — always do your own research.
How does ZBH compare to the S&P 500?
Over the past 23.8 years, $100 invested in ZBH would have grown to $264, compared to $1218 for the S&P 500. That's 4.1% annualized vs 11.1% for the index. ZBH has underperformed the broader market over this period.
Does ZBH pay a dividend?
Yes. Zimmer Biomet Holdings, Inc. currently pays a dividend yield of 116.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-05-01